|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A01K 67/027 | (2006.01) | ||
| C07K 14/705 | (2006.01) | ||
| C12N 15/85 | (2006.01) |
| (11) | Number of the document | 3157956 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15738177.3 |
| Date of filing the European patent application | 2015-06-19 | |
| (97) | Date of publication of the European application | 2017-04-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-02-05 |
| (46) | Date of publication of the claims translation | 2020-05-11 |
| (86) | Number | PCT/US2015/036649 |
| Date | 2015-06-19 |
| (87) | Number | WO 2015/196051 |
| Date | 2015-12-23 |
| (30) | Number | Date | Country code |
| 201462014181 P | 2014-06-19 | US | |
| 201462086518 P | 2014-12-02 | US | |
| 201562138221 P | 2015-03-25 | US |
| (72) |
BUROVA, Elena, US
MUJICA, Alexander O., US
LAI, Ka-Man Venus, US
MURPHY, Andrew J., US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Nepriklausantys žmonėms gyvūnai, turintys humanizuotą užprogramuotos ląstelių žūties 1 geną |
| NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE |
| Payment date | Validity (years) | Amount | |
| 2024-05-21 | 10 | 231.00 EUR |
| 2025-06-19 |